Frank Stenner-Liewen

Title: Frank Stenner-Liewen: Innovator in Death Domain Proteins

Introduction

Frank Stenner-Liewen is a notable inventor based in Homburg, Germany. He has made significant contributions to the field of molecular biology, particularly in the development of novel proteins that play crucial roles in various biological processes.

Latest Patents

Stenner-Liewen holds 1 patent related to Death Domain (DD) proteins. His patent describes the invention of novel DD, Death Effector Domain (DED), and NB-ARC domain proteins. The invention also includes nucleic acid molecules encoding these proteins, vectors containing these nucleic acids, and host cells that incorporate these vectors. Additionally, the patent provides antibodies that specifically bind to DDs, DEDs, or NB-ARC domains. These innovations are valuable for discovering drugs that can combat infections, autoimmunity, inflammation, allergies, allograft rejection, sepsis, and other diseases.

Career Highlights

Frank Stenner-Liewen is associated with the Burnham Institute, where he has been involved in groundbreaking research. His work has contributed to a deeper understanding of the mechanisms underlying various diseases, paving the way for potential therapeutic interventions.

Collaborations

Stenner-Liewen has collaborated with notable colleagues, including Loredana Fiorentino and Wilfried Roth. These partnerships have enhanced the scope and impact of his research endeavors.

Conclusion

Frank Stenner-Liewen is a distinguished inventor whose work on Death Domain proteins has the potential to lead to significant advancements in medical science. His contributions are vital for the development of new therapeutic strategies against various diseases.